James R Barnett1, Panagiotis Gikas2, Craig Gerrand2, Tim Wr Briggs2, Asif Saifuddin3. 1. Bone Tumour & Joint Reconstruction Unit, Royal National Orthopaedic Hospital, Stanmore, UK. jbarnett@doctors.org.uk. 2. Bone Tumour & Joint Reconstruction Unit, Royal National Orthopaedic Hospital, Stanmore, UK. 3. Radiology Department, Royal National Orthopaedic Hospital, Stanmore, UK.
Abstract
OBJECTIVE: Pre-operative whole-bone MRI is required to assess intra-osseous tumour extent and to identify skip metastases in cases of bone sarcoma. The current study aims to determine the sensitivity, specificity, and diagnostic accuracy of whole-bone MRI for the identification of skip metastases. MATERIALS AND METHOD: Review of 162 patients with long bone osteosarcoma or Ewing sarcoma who had undergone whole-bone MRI to assess intra-osseous tumour length and identify skip metastases. Comparison was made with post-chemotherapy MRI to look for a change in the appearance of suspected skip metastases, and resection specimens were assessed for the presence of skip metastases. The presence of local osseous recurrence was determined at final follow-up. RESULTS: There were 112 males and 50 females (mean age 18.8 years), with 119 osteosarcomas and 43 Ewing sarcomas. Skip metastases were diagnosed on whole-bone MRI in 23 cases (14.2%). In 2 cases, pre-operative needle biopsy diagnosed enchondromata, resulting in false positive diagnoses. Skip metastases were diagnosed in the resection specimens in 3 cases, and based on comparison with post-chemotherapy MRI in 12. There was no evidence of local osseous recurrence in 160 patients, while late recurrence occurred in 2 patients. Sensitivity was calculated as 88.2%, specificity as 97.6%, and diagnostic accuracy as 96.7%. CONCLUSION: Whole-bone MRI has a high sensitivity, specificity, and diagnostic accuracy for the identification of skip metastases in osteosarcoma and Ewing sarcoma. The possibility of false positive skip lesions and late local osseous recurrence is also highlighted.
OBJECTIVE: Pre-operative whole-bone MRI is required to assess intra-osseous tumour extent and to identify skip metastases in cases of bone sarcoma. The current study aims to determine the sensitivity, specificity, and diagnostic accuracy of whole-bone MRI for the identification of skip metastases. MATERIALS AND METHOD: Review of 162 patients with long bone osteosarcoma or Ewing sarcoma who had undergone whole-bone MRI to assess intra-osseous tumour length and identify skip metastases. Comparison was made with post-chemotherapy MRI to look for a change in the appearance of suspected skip metastases, and resection specimens were assessed for the presence of skip metastases. The presence of local osseous recurrence was determined at final follow-up. RESULTS: There were 112 males and 50 females (mean age 18.8 years), with 119 osteosarcomas and 43 Ewing sarcomas. Skip metastases were diagnosed on whole-bone MRI in 23 cases (14.2%). In 2 cases, pre-operative needle biopsy diagnosed enchondromata, resulting in false positive diagnoses. Skip metastases were diagnosed in the resection specimens in 3 cases, and based on comparison with post-chemotherapy MRI in 12. There was no evidence of local osseous recurrence in 160 patients, while late recurrence occurred in 2 patients. Sensitivity was calculated as 88.2%, specificity as 97.6%, and diagnostic accuracy as 96.7%. CONCLUSION: Whole-bone MRI has a high sensitivity, specificity, and diagnostic accuracy for the identification of skip metastases in osteosarcoma and Ewing sarcoma. The possibility of false positive skip lesions and late local osseous recurrence is also highlighted.
Authors: Matthew J Thompson; John C Shapton; Stephanie E Punt; Christopher N Johnson; Ernest U Conrad Journal: Clin Orthop Relat Res Date: 2018-03 Impact factor: 4.176
Authors: P Picci; L Sangiorgi; L Bahamonde; P Aluigi; J Bibiloni; M Zavatta; M Mercuri; A Briccoli; M Campanacci Journal: Ann Oncol Date: 1997-09 Impact factor: 32.976
Authors: Kaveh R Sajadi; Robert K Heck; Michael D Neel; Bhaskar N Rao; Najat Daw; Carlos Rodriguez-Galindo; Fredric A Hoffer; G Scott Stacy; Terrance D Peabody; Michael A Simon Journal: Clin Orthop Relat Res Date: 2004-09 Impact factor: 4.176